Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

SELL
$65.25 - $83.83 $2,544 - $3,269
-39 Reduced 5.92%
620 $47.3 Million
Q4 2024

Jan 30, 2025

BUY
$66.29 - $76.63 $16,439 - $19,004
248 Added 60.34%
659 $45.5 Million
Q3 2024

Oct 17, 2024

BUY
$62.0 - $79.01 $25,482 - $32,473
411 New
411 $30 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $22.2B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track V Square Quantitative Management LLC Portfolio

Follow V Square Quantitative Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V Square Quantitative Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Square Quantitative Management LLC with notifications on news.